Oncologic Emergencies Flashcards

(38 cards)

1
Q

In which groups of patients is incidence of hypercalcemia most common in?

A
  • NSC lung cancer
  • Breast cancer
  • Multiple myeloma
  • Squamous-cell cancers of the head and neck
  • Urothelial carcinomas
  • Ovarian cancers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What corrected calcium level defines mild hypercalcemia?

A

10.5 to 11.9 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What corrected calcium level defines moderate hypercalcemia?

A

12 to 13.9 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What corrected calcium level defines severe hypercalcemia?

A

14+ mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What other laboratory values should be tested for in hypercalcemia?

A
  • Serum phosphorous
  • PTH
  • Vitamin D
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the formula for corrected calcium?

A

0.8*(4 - albumin) + serum calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some S/S of hypercalcemia?

A
  • AKI
  • N/V
  • Lethargy/muscle weakness
  • Shortened QT interval
  • Arrhythmias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which etiology accounts for most cases of hypercalcemia?

A

Humoral (PTH-related peptide increased)
- increased calcium tubular reabsorption and phosphorus excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the rare causes of hypercalcemia?

A
  • Vitamin D toxicity
  • Ectopic PTH production by tumor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What treatment do we use to increase calcium excretion?

A

NS bolus of 1-2L, followed by 200-500 mL/hr infusion
Furosemide 20-40 mg (fluid overloaded or HF patients)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What treatments do we use to inhibit bone resorption?

A
  • Pamidronate (bisphosphonate)
  • Zoledronate (bisphosphonate)
  • Denosumab (RANKL-RANK binding inhibitor)
  • Calcitonin (direct inhibition and increased Ca2+ excretion)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What dose of pamidronate should we give to a patient with a corrected calcium >12?

A

90 mg IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What dose of zoledronic acid should we give to a patient with a corrected calcium >12?

A

4 mg IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Should you use bisphosphonates in renal impairment?

A

NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How many days do we wait before repeating bisphosphonate doses for hypercalcemia?

A

7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T/F: Denosumab should be avoided in renal impairment

17
Q

Why do we limit calcitonin treatment to 24-48 hours?

A

Tachyphylaxis

18
Q

What possible reserved options do we have if main therapies fail for hypercalcemia?

A
  • Steroids
  • Cinacalcet
  • Dialysis
19
Q

What labs are characteristic of tumor lysis syndrome?

A

↑ K
↑ Uric acid
↑ Phosphate

↓ Calcium

20
Q

What are risk factors for TLS?

A
  • High uric acid at baseline
  • Nephropathy
  • Hypotension
  • HF
21
Q

T/F: Low WBC leads to a higher risk of TLS

A

FALSE: High WBC is associated with TLS risk

22
Q

What is the treatment approach to TLS?

A
  • Monitor labs q4-6 hours
  • NS 150-300 mL/hr (NOT SODIUM BICARB)
  • Allopurinol / Rasburicase
23
Q

Which uric acid treatment comes first in high risk TLS patients?

24
Q

Which uric acid treatment comes first in intermediate risk TLS patients?

25
Generally allopurinol has no renal considerations unless what is present?
CKD
26
How do we treat hyperphosphatemia?
IV fluids + diuretics Maybe phosphate binders
27
T/F: We do not always correct hypocalcemia
TRUE: usually resolves when hyperphosphatemia is addressed Correction may introduce complications and hypercalcemia
28
What are risk factors for febrile neutropenia?
- Age >65 - Previous chemo or radiation - Pre-existing neutropenia or bone marrow tumor - Gender - Low BMI - Poor performance status - Comorbidities - Genetic polymorphisms
29
How is neutropenia defined?
ANC < 500 OR ANC <1000, expected to drop below 500 within 48 hours
30
How is fever defined?
Temperature >38.3 C OR Temperature >38 for over 1 hour
31
When do we give prophylaxis for LOW risk neutropenia?
Previous HSV infection
32
Which prophylaxis treatments should we consider/give for high or intermediate risk patients?
- Bacterial - Fungal - Viral - PJP
33
A MASCC score of at least WHAT indicates a low infection risk in febrile neutropenia?
21
34
What bacterial prophylaxis should be given to a low risk patient with febrile neutropenia?
Fluoroquinolone Cefepime if they're already taking a quinolone
35
What bacterial prophylaxis should be given to a high risk patient with febrile neutropenia?
Empiric IV options - Pip-tazo - Cefepime - Meropenem
36
When do we consider MRSA coverage?
- Catheter-related infections - SSTI - Pneumonia - Mucositis - Hemodynamic insufficiency or sepsis
37
When do we give fungal coverage in patients with febrile neutropenia?
- Hematologic malignancies - Hemodynamically unstable - Signs of sepsis - 7+ days of febrile neutropenia
38
What are the three ways we can treat hypercalcemia (mechanisms)?
- Increasing calcium excretion - Decreasing bone resorption - Reduced intestinal absorption of calcium